Can omega-3 fatty acids and vitamin E co-supplementation affect obesity indices?
A meta-analysis
Abstract
Abstract:Background: Studies have shown that vitamin E as an antioxidant protects omega-3 fatty acids (FAs) from oxidation. Several studies have evaluated the effect of omega-3 FAs and vitamin E co-supplementation on obesity indices; however, the results are inconsistent. The present systematic review and meta-analysis was conducted to address the role of omega-3 FAs plus vitamin E on obesity indices. Methods: Cochrane Library, PubMed, Scopus, Embase, and Web of Science databases were searched up to February 2022. Among all of the qualified studies, 10 articles were selected. The effect size was presented as weighted mean difference (WMD) and 95% confidence interval (CI). Fixed-effects model was employed to perform meta-analysis. Subgroup analysis and publication bias assessment were carried out. Results: Ten eligible randomized controlled trials comprising 558 participants were included. The average dose of omega-3 FAs and vitamin E co-supplementation in studies was 1000–4000 mg/day and 400 IU, respectively. Intervention duration varied from 6 to 16 weeks. There was no significant effect of omega-3 and vitamin E co-supplementation on body weight (BW) (WMD=0.14 kg; 95% CI: −0.13 to 0.42; p=0.297), and body mass index (BMI) (WMD=0.08, 95% CI: −0.01 to 0.16, p=0.073). However, subgroup analysis showed that it might increase BMI in women over 50 years and if the intervention lasted more than 8 weeks. Conclusion: There was no significant impact of combined omega-3 FAs and vitamin E supplementation on BW and BMI; however, it should be noted that the intervention has an increasing impact when supplementation duration was >8 weeks and in individuals with type 2 diabetes mellitus, >50 years old, and BMI>25 kg/m2.
References
1 . Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
2 . Prevalence and time trends in overweight and obesity among urban women: an analysis of demographic and health surveys data from 24 African countries, 1991–2014. BMJ Open. 2017;7(10):e017344.
3 . Socio-economic status over the life course and obesity: Systematic review and meta-analysis. PloS One. 2017;12(5):e0177151.
4 . Linking socioeconomic inequalities and type 2 diabetes through obesity and lifestyle factors among Mexican adults: a structural equations modeling approach. Salud Publica Mex. 2020;62(2):192–202.
5 . Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2018;11:647.
6 Meta-analysis on shift work and risks of specific obesity types. Obes Rev. 2018;19(1):28–40.
7 Neck circumference as a marker of overweight and obesity and cutoff values for bangladeshi adults. Indian J Endocrinol Metab. 2017;21(6):803.
8 . Anthropometric indicators and their applications for assessing population’s health condition. Hygeia. 2017;52(1):41–7.
9 Waist circumference, waist-to-height ratio and BMI percentiles in children aged 5 to 19 years in India: A population-based study. Obes Sci Pract. 2021;7(4):392–404.
10 . Waist to height ratio is the anthropometric index that most appropriately mirrors the lifestyle and psychological risk factors of obesity. Nutr Diet. 2019;76(5):539–45.
11 . Influence of different types of circuit training on the functional status and anthropometric parameters in young women with obesity. Minerva Ortop Traumatol. 2018;69(Suppl 1):86–9.
12 . Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncology. 2021;15(3):790–800.
13 . An assessment of the relationship of physical activity, obesity, and chronic diseases/conditions between active/obese and sedentary/normal weight American women in a national sample. Public Health. 2018;156:117–23.
14 . Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–23.
15 . Incretins in obesity and diabetes. Ann N Y Acad Sci. 2020;1461(1):104–26.
16 . Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.
17 . Hypertension in obesity and the impact of weight loss. Curr Cardiol Reps. 2017;19(10):1–8.
18 The effect of lifestyle changes on blood pressure control among hypertensive patients. Korean J Fam Med. 2017;38(4):173.
19 . High blood pressure and its relationship to adiposity in a school-aged population: body mass index vs waist circumference. Hypertens Res. 2018;41(2):135–40.
20 . Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients. 2019;11(7):1580.
21 . Time spent in sedentary posture is associated with waist circumference and cardiovascular risk. Int J Obes. 2017;41(5):689–96.
22 . The pathogenesis of obesity-associated adipose tissue inflammation. Adv Exp Med Biol. 2017;221–45.
23 . Inflammatory concepts of obesity. Int J Inflam. 2011;2011:529061.
24 . The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94(2):206–18.
25 The feasibility of two anthropometric indices to identify metabolic syndrome, insulin resistance and inflammatory factors in obese and overweight adults. Nutrition. 2019;57:194–201.
26 . A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α. Eur J Med Res. 2017;22(1):25.
27 Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio. Bosnian journal of basic medical sciences. 2019;19(4):328–35.
28 . Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome. Int J Vitam Nutr Res. 2020;90(5–6):477–83.
29 . Vitamin E function and requirements in relation to PUFA. Br J Nutr. 2015;114(8):1113–22.
30 . Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids. 1997;32(5):535–41.
31 Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J nutr. 1991;121(4):484–91.
32 , Guidance for developers of health research reporting guidelines. PLoS medicine. 2010;7(2):e1000217.
33 . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
34 Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients. Mol Nutr Food Res. 2016;60(2):390–8.
35 The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2017;125(06):353–9.
36 The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord. 2018;229:41–7.
37 The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein (a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017;439:247–55.
38 A randomized controlled clinical trial investigating the effects of omega-3 fatty acids and vitamin E co-supplementation on biomarkers of oxidative stress, inflammation and pregnancy outcomes in gestational diabetes. Can J Diabetes. 2017;41(2):143–9.
39 . A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes. J Clin Lipidol. 2016;10(2):386–93.
40 . The effects of omega-3 plus vitamin E and zinc plus vitamin C supplementation on cardiovascular risk markers in postmenopausal women with type 2 diabetes. Ther Adv Endocrinol Metab. 2014;5(4):67–76.
41 Metabolic response to omega-3 fatty acids and vitamin E Co-supplementation in patients with fibrocystic breast disease: a randomized, double-blind, placebo-controlled trial. Arch Iran Med. 2017;20(8):466–73.
42 . Effects of administration of omega-3 fatty acids with or without vitamin E on body composition in patients with coronary artery disease: a clinical trial. J Maz Univ Med Sci. 2016;25(133):25–36.
43 The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Neurochem Int. 2017;108:183–9.
44 Cold-pressed Nigella Sativa oil standardized to 3% thymoquinone potentiates omega-3 protection against obesity-induced oxidative stress, inflammation, and markers of insulin resistance accompanied with conversion of white to beige fat in mice. Antioxidants (Basel, Switzerland). 2020;9(6):489.
45 A combination of (ω-3) polyunsaturated fatty acids, polyphenols and L-carnitine reduces the plasma lipid levels and increases the expression of genes involved in fatty acid oxidation in human peripheral blood mononuclear cells and HepG2 cells. Ann Nutr Metab. 2011;58(2):133–40.
46 . Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev. 2009;10(6):648–59.
47 . Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity – a review. Nutrients. 2010;2(12):1212–30.
48 Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC pharmacol. 2004;4(1):1–9.
49 Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res. 2012;53(12):2726–33.
50 . Role of protein kinase C in obesity. Obes Med. 2020;18:100207.
51 . α-Tocopherol specifically inactivates cellular protein kinase C α by changing its phosphorylation state. Biochem J. 1998;334(1):243–9.
52 . Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90.
53 . Regulatory role of vitamin E in the immune system and inflammation. IUBMB life. 2019;71(4):487–94.
54 . A brief overview of oxidative stress in adipose tissue with a therapeutic approach to taking antioxidant supplements. Antioxidants. 2021;10(4):594.
55 . Oxidative stress-induced angiogenesis. J Clin Neurosci. 2019;63:13–6.
56 . The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression. J Cell Physiol. 2019;234(11):19384–92.
57 . Autoimmune mechanisms of scleroderma and a role of oxidative stress. Self Nonself. 2011;2(1):4–10.
58 . Inflammation precedes fat deposition in an experimental model of lymphedema. Lymphat Res Biol. 2021;19(2):116–25.
59 TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue. Cell. 2018;172(4):731–43.e12.
60 . Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trials. J Nutr Health Aging. 2017;21(2):187–92.
61 Can vitamin E supplementation affect obesity indices? A systematic review and meta-analysis of twenty-four randomized controlled trials. Clin Nutr. 2021;40(5):3201–9.